Shield Therapeutics's market cap is currently £42.19M. The company's EPS TTM is p-0.038; its P/E ratio is ―; Shield Therapeutics is scheduled to report earnings on April 24, 2025, and the estimated EPS forecast is p―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	£ 13.09M	£ 4.47M	£ 1.52M	£ 10.39M	£ 719.00K
Gross Profit	£ 4.03M	£ 2.00M	£ 539.00K	£ 9.03M	£ 234.00K
Operating Income	£ -31.33M	£ -25.71M	£ -19.95M	£ -1.89M	£ -9.04M
EBITDA	£ -30.29M	£ -37.39M	£ -17.35M	£ 820.00K	£ -6.40M
Net Income	£ -33.29M	£ -40.44M	£ -19.34M	£ -2.63M	£ -8.80M
Balance Sheet
Cash & Short-Term Investments	£ 10.94M	£ 2.82M	£ 12.12M	£ 2.94M	£ 4.14M
Total Assets	£ 48.80M	£ 22.07M	£ 44.41M	£ 32.53M	£ 36.32M
Total Debt	£ 20.25M	£ 6.10M	£ 156.00K	£ 28.00K	£ 20.00K
Net Debt	£ 6.30M	£ 3.28M	£ -11.96M	£ -2.91M	£ -4.12M
Total Liabilities	£ 33.77M	£ 16.65M	£ 3.38M	£ 2.25M	£ 4.17M
Stockholders' Equity	£ 11.79M	£ 5.43M	£ 41.03M	£ 30.28M	£ 32.15M
Cash Flow
Free Cash Flow	£ -40.07M	£ -20.14M	£ -18.80M	£ -1.42M	£ -5.45M
Operating Cash Flow	£ -37.13M	£ -18.25M	£ -16.74M	£ -1.40M	£ -4.07M
Investing Cash Flow	£ -2.43M	£ -1.70M	£ -2.05M	£ -20.00K	£ -1.37M
Financing Cash Flow	£ 49.66M	£ 7.71M	£ 27.58M	£ -47.00K	£ -203.00K

Currency in GBP

Shield Therapeutics Earnings and Revenue History

Income Statement >

Shield Therapeutics Debt to Assets

Balance Sheet >

Shield Therapeutics Cash Flow

Cash Flow >

Shield Therapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing